1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

Scientist in Hungary and Portugal get research boost


EMBO Installation Grants help establish labs for two scientists


Heidelberg, 29 July 2008 - Two talented life scientists will receive EMBO Installation Grants, assisting them to establish their research groups in Hungary and Portugal. These two scientists will receive funding in 2008 similar to the previous nine awardees announced in November 2007. The European Molecular Biology Organization (EMBO) introduced the scheme in 2006.


EMBO Installation Grants are awarded annually and aim to strengthen science in selected member states of the EMBC, the EMBO intergovernmental funding body. The EMBC Member States hosting the grantees generally finance the grants entirely. EMBC Member States participating in the scheme include Croatia, the Czech Republic, Estonia, Hungary, Poland, Portugal and Turkey.


Each scientist receives 50,000 euro annually for three to five years to help them establish their groups and themselves in the European scientific community. Grantees are integrated into the prestigious EMBO Young Investigator network, providing networking opportunities with some of Europe's best young group leaders and a range of career development programmes.


"EMBO congratulates these two scientists as recipients of the 2007 EMBO Installation Grants and welcomes them to the EMBO community," said Hermann Bujard, EMBO Executive Director. "These talented scientists will benefit from the secure financial backing of their host countries plus the active interest and support of EMBO in their scientific and professional development. They represent a promising scientific future for the countries receiving them and for Europe as a whole."


A committee of EMBO Members selected the successful candidates for the high standard of their research. By bringing this level of scientific talent into the participating countries, EMBO hopes to improve the competitiveness of these countries in European science.


Gergely Szakács is moving from the USA to set up his laboratory at the Hungarian Academy of Sciences in Budapest, Hungary to research multidrug resistance in cancer. Szakács is the third awardee to establish a lab in Hungary of the total 11 scientists receiving the 2007 EMBO Installation Grants.


In Portugal, Monica Bettencourt-Dias's group is researching cell cycle links to cancer at the Gulbenkian Institute in Oeiras. Bettencourt-Dias moves from the UK and is the second awardee to set up in Portugal of the 11 grantees for 2007. Portugal's Foundation for Science & Technology (FCT) and the Gulbenkian Institute will share payment of the Dias grant.


Recipients of the 2008 EMBO Installation Grants will be announced in November 2008.


2007 EMBO Installation Grantees

Two of the nine grantees will establish groups in the Czech Republic, three in Hungary, two in Turkey, one in
Croatia, one in Poland and two in Portugal. Five scientists will move from positions in the USA, three will move from the UK, two from Switzerland and one will move from Sweden.


Name Moving to Moving from
Bryja, Vítĕzslav Masaryk University, Brno, CZ Karolinska Institute, Stockholm, SE
Research area: Wnt pathway activation

Çelik, Arzu Boğaziçi University, Istanbul, TR New York University, US
Research area: Photoreceptor differentiation

Monica Bettencourt-Dias Gulbenkian Institute, Oeiras, PT University of Cambridge, UK
Research area: Cell cycle links to cancer

Dobrzyń, Agnieszka Nencki Institute (of Experimental Biology), Warsaw, PL University of Wisconsin-Madison, US
Research area: Lipid-induced insulin resistance

Pál, Csaba Biological Research Center, Szeged, HU University of Oxford, UK
Research area: Evolutionary systems biology

Reményi, Attila Eötvös Lorand University, Budapest, HU University of California San Francisco (UCSF), US
Research area: Protein-protein interactions

Gergely Szakács Hungarian Academy of Sciences,
Budapest, HU
Center for Cancer Research, Bethesda, US
Research area: Multidrug resistance in cancer

Vaňáčova, Štěpénka Masaryk University, Brno, CZ Biozentrum Basel, CH
Research area: Nuclear RNA quality control

Veiga-Fernandes, Henrique Instituto de Medicina Molecular (IMM), Lisbon, PT National Institute of Medical Research (NIMR), London, UK
Research area: Lymphocyte development

Yaman, Ibrahim Marmara Research Center, Gebze, TR Case Western Reserve University, Cleveland, US
Research area: Ochratoxin A carcinogenicity

Žagrović, Bojan Mediterranean Institute for Life Sciences (MILS), Split, HR Swiss Federal Institute of Technology (ETH) Zurich, CH
Research area: Molecular structure and dynamics


This email address is being protected from spambots. You need JavaScript enabled to view it.


Tilmann KießlingTilmann Kießling
Head, Communications
T. + 49 160 9019 3839